Business
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
Hi, what are you looking for?
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
"Although colon cancer can be classified as preventable or curable with the aid of early screening, many patients have been reluctant to undergo currently...
The ubiquitin system produces a protein that greatly restricts the development of cancerous tumors.
The team identified one potential drug molecule that performed quite well, even causing many of the cancer cells to die.
"The completion of the development of our commercial A3AR biomarker test kit comes at a very important time since we plan to use the...
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
Laura Perlmutter wrote in a release, "We are confident that this collaborative effort ... will lead to dramatic results in the fight against this...
Company just completed Phase II/III psoriasis trial and expects to release top line data in Q1 2015
While the diagnosis of an impending death is always sad, it can be important for patients, families, and clinicians as they make...
Israel’s Micromedic Technologies which specializes in the development and commercialization of cancer diagnostic products announced the results of a blinded, multi-center clinical study using...